Top compounds associated with response to MTFR1L


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.4
mRNA BRD1835 CTRPv2 pan-cancer AAC -0.03 0.4
mRNA bafilomycin A1 CTRPv2 pan-cancer AAC 0.11 0.5
mRNA tigecycline CTRPv2 pan-cancer AAC 0.037 0.5
mRNA pac-1 GDSC1000 pan-cancer AAC -0.03 0.5
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC 0.03 0.5
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.5
mRNA GSK-J4 CTRPv2 pan-cancer AAC 0.081 0.5
mRNA Crizotinib gCSI pan-cancer AAC -0.047 0.5
mRNA TAE684 CTRPv2 pan-cancer AAC -0.028 0.5
Download CSV